<DOC>
	<DOCNO>NCT00988338</DOCNO>
	<brief_summary>The purpose study utilize Trinity Evolution graft source foot/ankle fusion follow subject measure clinical outcome fusion rate . The hypothesis study Trinity Evolution result fusion rate clinical outcome similar obtain autograft routinely use allograft material ; include : fusion , improvement pain , improvement function , absence adverse event relate use graft source .</brief_summary>
	<brief_title>Evaluation Trinity Evolution Patients Undergoing Foot Ankle Fusion</brief_title>
	<detailed_description>Symptomatic arthritic condition foot ankle include osteoarthritis , post-traumatic arthritis , inflammatory arthropathy others painful disable condition lead reduce quality life . Major symptom include pain , stiffness , swell , difficulty walk . Many patient may initially treatable non-invasive measure analgesic , ankle-foot orthosis , physical therapy medication steroid ; however , time , surgery becomes necessary improve quality life maintain function . Arthrodesis well-known procedure reduce pain result foot/ankle withstand active lifestyle . Bone graft use stimulate new bone formation operative site provide osteogenic cell osteoinductive factor osteoconductive matrix . Although autologous bone often used structural graft material fusion procedure , donor site morbidity ( e.g. , pain , infection , fracture ) , limited supply , inconsistent osteogenic activity continue associate problem . The quality autograft dependent upon age medical condition patient , well number viable mesenchymal osteoprogenitor stem cell present specimen . This tissue harvest surgical procedure ; process prolong morbidity harvest site . The ideal bone graft would offer osteogenic cell , osteoinductive factor , osteoconductive matrix consistent supply viable mesenchymal stem cell ( MSCs ) osteoprogenitor cell ( OPCs ) —but without morbidity autograft . Due limitation associate autograft , researcher pursue use bone-graft substitute promote arthrodesis . Bone-graft substitute use surgeon include ceramic synthetic , bone morphogenic protein ( BMPs ) , demineralize bone matrix ( DBMs ) allograft ; may use alone combination . Allografts available substitute autograft offer benefit autograft without limitations—but contain viable MSCs OPCs . Trinity Evolution allogeneic cancellous bone matrix contain demineralized cortical bone ( DCB ) well viable osteoprogenitor mesenchymal stem cell . Adult mesenchymal stem cell osteoprogenitor cell , Trinity Evolution , precursor cell differentiate osteoblasts—the cell responsible bone growth repair . Trinity Evolution provide required osteoconduction , osteogenesis , osteoinductivity necessary successful bone grafting . It offer viable osteoprogenitor mesenchymal stem cell demineralized cortical bone—all single product . Data preclinical study Trinity Evolution demonstrate in-vitro in-vivo safety effectiveness . Trinity Evolution `` minimally manipulate '' tissue consider allograft , , label bone repair orthopedic podiatric indication autograft use . In study , Trinity Evolution use substitute autograft and/or standard allograft follow arthrodesis procedure : tibiotalar , subtalar , calcaneocuboid , talonavicular , double fusion ( i.e . calcaneocuboid talonavicular ) , triple fusion ( i.e . subtalar , calcaneocuboid , talonavicular ) .</detailed_description>
	<criteria>Foot and/or ankle pathology require fusion use open surgical technique supplemental bone graft/substitute require one follow procedure : Ankle joint fusion Subtalar fusion Calcaneocuboid fusion Talonavicular fusion Double fusion ( talonavicular calcaneocuboid joint ) Triple fusion ( subtalar , talonavicular , calcaneocuboid joint ) At least 18 year age Willing able comply requirement protocol include followup requirement Willing able sign studyspecific inform consent . Use bone graft bone graft substitute addition place Trinity Evolution time surgery Use adjunctive postoperative stimulation Active local systemic infection Currently pregnant consider become pregnant followup period Active malignancy chemotherapy kind malignancy past 1 year Immunosuppressive therapy kind within past 1 year Has know history hypersensitivity anaphylactic reaction dimethyl sulfoxide ( DMSO ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Trinity Evolution</keyword>
	<keyword>Arthrodesis</keyword>
	<keyword>Foot Fusion</keyword>
	<keyword>Ankle Fusion</keyword>
	<keyword>Allograft</keyword>
</DOC>